1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Tallac Therapeutics, Inc.

Have updates for this profile?  Please contribute data

About Employee data
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

Burlingame CA US

Primary Industry

Biotechnology

About

Founded in 2018 and based in California, US, Tallac Therapeutics, Inc., formerly known as Tollnine, Inc., operates as a biopharmaceutical company that develops immunotherapies for the treatment of cancer.
Current Investors
VenBio Partners, Lightstone Ventures, MPC

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Specialty Pharmaceuticals, Pharmaceutical Research & Development
Website
www.tallactherapeutics.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo